DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Lactose (India) Ltd?

Lactose (India) Ltd has a price-to-earnings (PE) ratio of 18.2 in the Healthcare sector.

What is the market capitalisation of Lactose (India) Ltd?

Lactose (India) Ltd has a market capitalisation of approximately ₹126 crore.

Is Lactose (India) Ltd a profitable company?

Lactose (India) Ltd generates a return on equity of 9.8% with a net profit margin of 4.3%. That is a modest return on shareholder capital.

What is the 52-week high and low of LACTOSEINDIALTD?

Lactose (India) Ltd (LACTOSEINDIALTD) has traded between ₹76.01 and ₹136.7 over the past 52 weeks.

Lactose (India) Ltd

₹0.00▲ +0.00 (+0.00%)

LACTOSEINDIALTD·NSE·Healthcare

Market Cap

125.62 Cr

PE Ratio

18.20

Volume

—

Day High - Low

—

52W High-Low

136.70 - 76.01

₹0.00▲ +0.00 (+0.00%)

Market Cap125.62 Cr

PE Ratio18.20

Volume—

Day High - Low—

52W High-Low136.70 - 76.01

Lactose (India) Ltd (LACTOSEINDIALTD): company summary

Lactose (India) Ltd (LACTOSEINDIALTD) is a micro-cap Healthcare company valued at ₹126 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance: Revenue has been growing strongly at 35.3% a year over three years; profit grew 94.9% a year, ahead of revenue — margins are expanding. Return on equity is 9.8%.
Valuation multiples: The stock trades at 18.2 times earnings, a discount to the Healthcare median of 32.0, 1.95 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.

DocStoX Score

5.9/10

Fair

Fair Value

ROE

9.81%

Average

P/E

18.20x

Fair

Debt / Equity

0.95

Moderate

Industry

Healthcare

Pharmaceuticals

Overall View

Fair

Price performance

52W₹76.01

₹136.70

DocStoX take

Supported by growth (10.0), but weakest on valuation (4.1). Scored on 4 of 5 measures.

DocStoX score

Medium confidence

5.9

/10

Fair

Quality

Solid

ROE 9.8%

Valuation

Rich

P/E 18.2×

Growth

Strong

Revenue +36.1% 5Y CAGR

Risk

Elevated

D/E 0.95

Momentum

No data

No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

—

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹126 Cr

52W High / Low

₹137 / ₹76

Dividend Yield

0.00%

Promoter Holding

53.65%

EPS (TTM)

₹4.10

Book Value

₹51.46

Key highlights

Profit compounding 95% a year
Revenue compounding 36% a year
Profitable in all of the last 5 years
Small ₹126 cr company — thinner liquidity

3 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Lactose (India) Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Lactose (India) Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Lactose (India) Ltd with peers

Lactose (India) Ltd vs Sun Pharmaceutical Industries Limited Lactose (India) Ltd vs Divi's Laboratories Limited Lactose (India) Ltd vs Torrent Pharmaceuticals Limited Lactose (India) Ltd vs Apollo Hospitals Enterprise Limited Lactose (India) Ltd vs Zydus Lifesciences Limited Lactose (India) Ltd vs Laurus Labs Limited

Related tools & concepts

Value Lactose (India) Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

LACTOSEINDIALTD newsLatest coverage & filings Open screenerFilter the whole market